Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice

Author： Ferrer-Font Laura Villamañan Lucia Arias-Ramos Nuria Vilardell Jordi Plana Maria Ruzzene Maria Pinna Lorenzo A. Itarte Emilio Arús Carles Candiota Ana Paula

Publisher： MDPI

E-ISSN： 1424-8247|10|1|24-24

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.10, Iss.1, 2017-02, pp. : 24-24

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural Determinants of CX-4945 Derivatives as Protein Kinase CK2 Inhibitors: A Computational Study

By Liu Hongbo Wang Xia Wang Jian Wang Jinghui Li Yan Yang Ling Li Guohui

International Journal of Molecular Sciences, Vol. 12, Iss. 10, 2011-10 ,pp. : 7004-7021

MDPI

Access to resources Recommend Favorite

D11-Mediated Inhibition of Protein Kinase CK2 Impairs HIF-1α-Mediated Signaling in Human Glioblastoma Cells

By Schaefer Susanne Svenstrup Tina H. Fischer Mette Guerra Barbara

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

The Link between Protein Kinase CK2 and Atypical Kinase Rio1

By Kubiński Konrad Masłyk Maciej

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 21-21

MDPI

Access to resources Recommend Favorite

Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks

By Nuñez de Villavicencio-Diaz Teresa Rabalski Adam J. Litchfield David W.

Pharmaceuticals, Vol. 10, Iss. 1, 2017-03 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

The Phosphorylation of PDX-1 by Protein Kinase CK2 Is Crucial for Its Stability

By Klein Sabrina Meng Rui Montenarh Mathias Götz Claudia

Pharmaceuticals, Vol. 10, Iss. 1, 2016-12 ,pp. : 2-2

MDPI

Access to resources Recommend Favorite